ANKRD17 and lung carcinoma: Still, given that ANKRD17 has been shown to induce JAK/STAT signaling pathways in a variety of cancers, and increased levels of ANKRD17 correlate with poorer prognosis in lung cancer patients [31,32,33], we considered it an interesting novel player.